Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 303

Similar articles for PubMed (Select 19110358)

1.

Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC.

Am J Kidney Dis. 2009 Apr;53(4):596-605. doi: 10.1053/j.ajkd.2008.10.044. Epub 2008 Dec 24.

2.

Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort.

Kucharska-Newton AM, Couper DJ, Pankow JS, Prineas RJ, Rea TD, Sotoodehnia N, Chakravarti A, Folsom AR, Siscovick DS, Rosamond WD.

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2182-90. doi: 10.1161/ATVBAHA.109.192740. Epub 2009 Oct 1.

3.

Does inflammation fuel the fire in CKD?

Rifkin DE, Sarnak MJ.

Am J Kidney Dis. 2009 Apr;53(4):572-5. doi: 10.1053/j.ajkd.2009.01.001. No abstract available.

4.

Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.

Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J.

Am J Kidney Dis. 2010 Apr;55(4):648-59. doi: 10.1053/j.ajkd.2009.12.016. Epub 2010 Feb 26.

5.

Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.

Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, Kim WS, Suh BS, Jeong C, Yoon K.

Am J Kidney Dis. 2009 Jan;53(1):59-69. doi: 10.1053/j.ajkd.2008.07.027. Epub 2008 Oct 5. Erratum in: Am J Kidney Dis. 2009 May;53(5):913.

PMID:
18838200
6.

Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.

Prizment AE, Anderson KE, Visvanathan K, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):297-307. doi: 10.1158/1055-9965.EPI-10-1146. Epub 2011 Jan 7.

8.

Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK.

Circulation. 1999 Aug 17;100(7):736-42.

9.

Serum bicarbonate and long-term outcomes in CKD.

Menon V, Tighiouart H, Vaughn NS, Beck GJ, Kusek JW, Collins AJ, Greene T, Sarnak MJ.

Am J Kidney Dis. 2010 Nov;56(5):907-14. doi: 10.1053/j.ajkd.2010.03.023. Epub 2010 Jun 3.

PMID:
20605301
10.

Association of kidney function and albuminuria with prevalent and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) study.

Huang M, Matsushita K, Sang Y, Ballew SH, Astor BC, Coresh J.

Am J Kidney Dis. 2015 Jan;65(1):58-66. doi: 10.1053/j.ajkd.2014.06.025. Epub 2014 Aug 21.

PMID:
25151408
11.

Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults.

Erlinger TP, Tarver-Carr ME, Powe NR, Appel LJ, Coresh J, Eberhardt MS, Brancati FL.

Am J Kidney Dis. 2003 Aug;42(2):256-63.

PMID:
12900806
12.

Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.

Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG.

Ann Intern Med. 2000 Jul 18;133(2):81-91.

PMID:
10896647
13.

Serum uric acid and chronic kidney disease: the Severance cohort study.

Mok Y, Lee SJ, Kim MS, Cui W, Moon YM, Jee SH.

Nephrol Dial Transplant. 2012 May;27(5):1831-5. doi: 10.1093/ndt/gfr530. Epub 2011 Sep 21.

14.

Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.

Bhavsar NA, Köttgen A, Coresh J, Astor BC.

Am J Kidney Dis. 2012 Aug;60(2):233-40. doi: 10.1053/j.ajkd.2012.02.336. Epub 2012 Apr 28.

15.
16.

Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population.

O'Seaghdha CM, Hwang SJ, Bhavsar NA, Köttgen A, Coresh J, Astor BC, Fox CS.

Am J Kidney Dis. 2011 Jun;57(6):841-9. doi: 10.1053/j.ajkd.2010.11.022. Epub 2011 Feb 3.

17.

Association of arterial rigidity with incident kidney disease and kidney function decline: the Health ABC study.

Madero M, Peralta C, Katz R, Canada R, Fried L, Najjar S, Shlipak M, Simonsick E, Lakatta E, Patel K, Rifkin D, Hawkins M, Newman A, Sarnak M; Health ABC Study.

Clin J Am Soc Nephrol. 2013 Mar;8(3):424-33. doi: 10.2215/CJN.07900812. Epub 2012 Dec 27.

18.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
19.

Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.

Goicoechea M, de Vinuesa SG, Gómez-Campderá F, Aragoncillo I, Verdalles U, Mosse A, Luño J.

Kidney Int Suppl. 2008 Dec;(111):S67-70. doi: 10.1038/ki.2008.519.

20.

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D.

JAMA. 2011 Apr 20;305(15):1545-52. doi: 10.1001/jama.2011.468. Epub 2011 Apr 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk